Top compounds associated with response to KMT2B


Feature Type Standardized
Nominal ANOVA
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.21 2e-07
mRNA PX-12 CTRPv2 pan-cancer AAC 0.16 2e-07
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 4e-07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA PL-DI CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.18 6e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 6e-06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 6e-06
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-05
Download CSV